Department of Department of Dental Clinical Specialties Faculty of Dentistry, Complutense University of Madrid Plaza Ramón y Cajal s/n, 28040, Madrid, Spain
Med Oral Patol Oral Cir Bucal. 2023 Jul 1;28(4):e371-e377. doi: 10.4317/medoral.25792.
Zygomatic implants have been used to treat severe atrophy maxilla. Since its description, the technique has been improved in order to reduce patient morbidity as well as prosthesis rehabilitation time. Despite the improvements in the procedure, zygomatic implant treatments still have complications related to the peri-implant soft-tissue; a probing depth greater than 6 millimeter (mm) and a prevalence of bleeding on probing of 45% have been described. The mobilization of the buccal fat has been used to manage different oral and maxillofacial soft-tissue pathologies. The aim of this study was to assess whether the buccal fat pad might prevent mucosal dehiscence and avoid potential postoperative complications when is placed covering the body part of the zygomatic implants.
In this pilot study, 7 patients were enrolled and a total of 28 zygomatic implants were placed and evaluated during a 12-month follow-up period. Surgical sites were randomly divided into two groups before implant placement: control group (A; in which no buccal fat pad was applied) and experimental group (B). Peri-implant soft tissue thickness difference, pain using a Visual Analog Scale (VAS), swelling, hematoma, buccal soft tissue healing and sinusitis, were evaluated. The implant survival rate was determined according the Aparicio success criteria and compared between the control and experimental procedure.
A nonstatistical difference was found between groups regarding to pain. The experimental group showed higher soft-tissues thickness (p= 0.03) and the implant survival rate was 100% in both groups.
The mobilization of the buccal fat pad to cover the body of the zygomatic implants increases peri-implant soft-tissue thickness, without increasing the postoperative pain.
颧骨种植体已被用于治疗严重上颌萎缩。自描述以来,该技术已得到改进,以降低患者发病率和义齿修复时间。尽管手术有所改进,但颧骨种植体治疗仍存在与种植体周围软组织相关的并发症;已描述了大于 6 毫米(mm)的探测深度和 45%的探诊出血率。颊脂垫的动员已被用于治疗不同的口腔和颌面软组织疾病。本研究旨在评估颊脂垫是否可以防止黏膜裂开,并在放置覆盖颧骨种植体体部时避免潜在的术后并发症。
在这项初步研究中,纳入了 7 名患者,并在 12 个月的随访期间共放置和评估了 28 个颧骨种植体。在放置种植体之前,手术部位被随机分为两组:对照组(A;其中未应用颊脂垫)和实验组(B)。评估了种植体周围软组织厚度差异、使用视觉模拟量表(VAS)的疼痛、肿胀、血肿、颊部软组织愈合和鼻窦炎。根据 Aparicio 成功标准确定种植体存活率,并比较对照组和实验组之间的差异。
两组间疼痛无统计学差异。实验组软组织厚度较高(p=0.03),两组种植体存活率均为 100%。
颊脂垫的动员以覆盖颧骨种植体的体部可增加种植体周围软组织的厚度,而不会增加术后疼痛。